SCM
AEGR
Sarissa Capital Management’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-2,649,000
| Closed | -$7.87M | – | 15 |
|
|
2016
Q3 | $7.87M | Hold |
2,649,000
| – | – | 1.81% | 8 |
|
|
2016
Q2 | $3.95M | Buy |
2,649,000
+69,000
| +3% | +$103K | 1.12% | 12 |
|
|
2016
Q1 | $9.55M | Hold |
2,580,000
| – | – | 2.1% | 10 |
|
|
2015
Q4 | $26.1M | Buy |
2,580,000
+25,000
| +1% | +$253K | 5.07% | 8 |
|
|
2015
Q3 | $34.7M | Buy |
2,555,000
+518,171
| +25% | +$7.05M | 8.58% | 5 |
|
|
2015
Q2 | $38.6M | Buy |
2,036,829
+399,374
| +24% | +$7.58M | 8.89% | 5 |
|
|
2015
Q1 | $42.9M | Buy |
+1,637,455
| New | +$42.9M | 9.04% | 5 |
|